The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses
Author:
Publisher
Frontiers Media SA
Subject
Clinical Neurology,Neurology
Reference56 articles.
1. Evidence based medicine—new approaches and challenges;Masic;Acta Inform Med,2008
2. Natural history of multiple sclerosis;Weinshenker;Ann. Neurol.,1994
3. Defining the clinical course of multiple sclerosis. The 2013 revisions;Lublin;Neurology,2014
4. Ocrelizumab versus placebo in primary progressive multiple sclerosis;Montalban;N Eng J Med.,2017
5. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study;Kappos;Lancet,2018
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of a Quality Measure for Multiple Sclerosis Care: Disease-Modifying Therapy Initiation at the University of North Carolina’s Outpatient Neurology Clinic;International Journal of MS Care;2024-09-09
2. Environmental factors related to multiple sclerosis progression;Journal of the Neurological Sciences;2024-09
3. Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates;Multiple Sclerosis and Related Disorders;2024-08
4. Stem cell therapies: a new era in the treatment of multiple sclerosis;Frontiers in Neurology;2024-05-09
5. Lifestyle management and brain MRI metrics in female Australian adults living with multiple sclerosis: a feasibility and acceptability study;Pilot and Feasibility Studies;2024-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3